Maximus logo

Maximus Review

Best for: men seeking compounded GLP-1 alongside testosterone optimization

Maximus is a men's health platform offering compounded semaglutide (from ~$99/mo) and compounded tirzepatide alongside testosterone replacement therapy and longevity treatments. Available in all 50 states + DC. Microdose protocol available for patients with less weight to lose.

By Eli Marsden · Founding Editor
Editorially reviewed (not clinically reviewed) · How we verify contentLast reviewed
7.0
★★★3.5
CompoundedMicrodose OptionsSemaglutideTirzepatideMen's Health
$149.99/mo
Same price at every dose

What the monthly price covers

Medication

Included

Provider visits

Not disclosed

Shipping

Included

Lab work

Not disclosed

Coaching

Not disclosed

See plans →

No insurance neededVetted by our editors

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

The Bottom Line

Maximus is a solid telehealth option with balanced features and pricing.

Score: 7/10Best for: men seeking compounded GLP-1 alongside testosterone optimizationFrom: $149.99/mo
Maximus logo
3.5 / 5
Our editorial rating
Visit Maximus

from $149.99/mo · no insurance needed

Maximus at a glance

Type
GLP-1 telehealth provider
Medications
Semaglutide, Tirzepatide
Starting price
$149.99/mo (Starting at; flat monthly plan includes access to all dose tiers)
Pricing model
Flat — dose increases don't raise the monthly price
What's included
Medication · Shipping
Availability
All 50 states
FDA status
No FDA warning letter on record

How we scored Maximus

Each dimension is scored algorithmically from Maximus’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.

Value25%

7.7/10

At $149.99/mo, Maximus runs about 12% below the $170 median for GLP-1 providers. Pricing is flat across doses, so there is no escalation markup as you titrate up.

Effectiveness25%

7.3/10

Maximus offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.

User Experience15%

6.1/10

Online intake and platform experience; 5 platform features disclosed.

Trust & Safety15%

7.2/10

Core details confirmed by our editors; no FDA warning letters on file; dispenses through an accredited compounding pharmacy (last checked 2026-06-06).

Accessibility10%

7.5/10

Maximus treats patients in all 50 states.

Support10%

5.1/10

Maximus provides standard clinician follow-up; no extended coaching or community program is disclosed.

How we verified this Maximus review

Last checked 2026-06-06
  • Confirmed current pricing across 2 dose/plan tiers
  • Confirmed availability in all 50 states
  • Confirmed what the monthly price does and doesn't include
  • Checked the FDA warning-letter database for enforcement actions
  • Walked the public intake/checkout flow on the provider's site

Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.

GLP-1 medications Maximus offers

Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.

Peptides Maximus offers

Beyond GLP-1s, Maximus also offers these peptides — tap any for our evidence-based guide.

Pricing

Semaglutide (GLP-1, flat-rate, all dose tiers)Compounded
$149.99/mo
semaglutide

Starting at; flat monthly plan includes access to all dose tiers

Tirzepatide (GLP-1 + GIP, flat-rate, all dose tiers)Compounded
$249.99/mo
tirzepatide

Starting at; dual-action GLP-1 + GIP; flat across dose tiers

Ready to get started?

Plans and promotions change often — check Maximus's current pricing and active discounts before you decide.

See Maximus pricing →

What we like

  • All 50 states + DC coverage
  • Microdose GLP-1 protocol for patients with less weight to lose
  • Established men's health brand
  • Semaglutide from $149.99/mo and tirzepatide from $249.99/mo, flat-rate plans including all dose tiers

Watch-outs

  • No LegitScript or PCAB certification found
  • BBB F rating reported by third-party reviewers — complaints about unfulfilled prescriptions
  • Men's health platform — TRT is the core product, GLP-1 is secondary
  • Compounded only — no brand-name options

Maximus: a men's optimization brand that added GLP-1, not a weight-loss clinic that added everything else

Maximus built its name on testosterone and longevity protocols for men, and that origin tells you most of what you need to know before signing up for its weight-loss program. Compounded semaglutide and tirzepatide are real offerings here, available in all 50 states plus DC, but they sit alongside TRT and other men's-health treatments rather than being the main event. If you're a man who wants to lose weight while also working with a platform that handles hormones and broader optimization, that bundling is the whole appeal. If you just want a focused, no-frills GLP-1 program, you're shopping at a store where weight loss is one aisle, not the front door.

How the pricing actually works: flat monthly, every dose included

Maximus uses a flat-rate model, which is genuinely the most patient-friendly part of the offer. Compounded semaglutide starts at $149.99 a month, and that single price includes access to all dose tiers — so when your prescriber moves you up the dose ladder, your bill doesn't climb with it. That matters, because plenty of compounding telehealth brands quietly raise the monthly charge each time your dose increases. The dual-action tirzepatide plan runs noticeably higher, in the mid-two-hundreds per month, but follows the same all-tiers-included logic. For comparison, the category median across providers we track sits at $170, so Maximus's semaglutide plan lands below the middle of the pack while its tirzepatide plan sits above it.

Medication and shipping are folded into that monthly price, and Maximus advertises free, discreet shipping — a small but real plus for anyone who'd rather their packages not announce what's inside.

One pricing caveat worth reading the fine print on

Maximus's refund language refers to returning your money "minus the cost of the doctor consultation," which strongly implies there's a consultation charge baked in somewhere even though the company doesn't spell it out as a separate headline line. Before you commit, ask support directly what the upfront visit costs and what's actually refundable if the program isn't for you. Don't assume the monthly figure is the only money that leaves your account.

The medications: compounded only, with a microdose option that's actually thoughtful

Everything Maximus dispenses for weight loss is compounded — there are no brand-name Wegovy or Zepbound options here. That keeps the price down but means you're relying on a compounding pharmacy's formulation rather than an FDA-approved finished product, the standard trade-off across this corner of telehealth. You get the two workhorse molecules: semaglutide (the GLP-1 in Ozempic and Wegovy) and tirzepatide (the dual GLP-1/GIP agent in Mounjaro and Zepbound).

The standout clinical touch is the microdose protocol. Maximus offers lower-dose GLP-1 plans aimed at people who don't have a large amount of weight to lose — someone targeting the last ten or fifteen pounds rather than a major reduction. A lot of providers only think in terms of the standard escalating dose ladder, so a deliberate low-dose lane is a genuine point of difference and a sign someone designed the program around real patient variety.

Where the trust questions are real

This is the part to take seriously. We could not find LegitScript certification or PCAB accreditation for Maximus's compounding supply chain — credentials we like to see and that some competitors display openly. On top of that, third-party reviewers have reported a BBB F rating, with complaints specifically about prescriptions that weren't fulfilled. That's not a minor cosmetic gripe; an unfilled prescription is the one failure that actually defeats the purpose of paying for the service.

None of that means the medication you receive is unsafe — there are no FDA warning letters on file against the platform, and the molecules themselves are well-studied. But the absence of visible accreditation plus documented fulfillment complaints is exactly the kind of operational risk that should temper your expectations and push you to start with a single month before committing to anything longer. You can read how we weigh these signals in our scoring methodology.

Who should choose Maximus, and who should walk

Maximus makes the most sense for one specific person: a man who wants to combine GLP-1 weight loss with testosterone or broader optimization under a single login, and who values the flat all-doses-included pricing enough to accept the trust caveats. The microdose option also makes it worth a look for anyone — within its men's-health framing — chasing a modest amount of weight loss rather than a dramatic one.

  • Good fit: men already interested in TRT or longevity care who want weight loss bundled in
  • Good fit: patients who want predictable pricing that doesn't rise with each dose increase
  • Good fit: people targeting a smaller amount of weight loss who want a true microdose plan
  • Skip it: anyone who wants brand-name semaglutide or tirzepatide rather than compounded
  • Skip it: women, or anyone wanting a dedicated weight-loss clinic where GLP-1 is the primary focus
  • Skip it: patients who won't proceed without visible LegitScript/PCAB credentials and a clean complaint record

Bottom line

Maximus offers a legitimately appealing structure — flat monthly pricing with all dose tiers included, a thoughtful microdose lane, nationwide availability, and the convenience of weight loss alongside men's hormone care. The semaglutide plan in particular is priced below the category median. But the unanswered consultation-fee question, the missing compounding accreditations, and the reported fulfillment complaints are real reasons to go in cautiously. If you're the man this platform was built for, start with one month, confirm every charge in writing before you pay, and judge the fulfillment for yourself before you rely on it long-term.

For a side-by-side, DudeMeds ($149/month) and bmiMD ($99/month) are the most comparable options to weigh against Maximus.

Ready to start with Maximus?

Starting at $149.99/month. See current pricing and start your free consultation.

Maximus might not be your best fit if…

We rank editorially, so here’s where a different provider we track may serve you better.

  • If you want brand-name Ozempic, Wegovy, Mounjaro or Zepbound, consider Gala.
  • If the lowest possible monthly price is your top priority, consider Telos Rx (from $49/mo).
  • If you want built-in coaching and behavior-change support, consider Found.

Alternatives to Maximus

8.6/ 10
Verified partner

Enhance MD

Best for: lab-monitored compounded GLP-1 with mandatory video visit

★★★★4.3

Editorial score · methodology

$49/mo
CompoundedSemaglutideTirzepatide
Get StartedRead full Enhance MD review →
8.5/ 10
Verified partner

Embody

Best for: lowest first-month entry pricing on compounded GLP-1s

★★★★4.3

Editorial score · methodology

$99/mo
CompoundedSemaglutideTirzepatide
Get StartedRead full Embody review →
8.5/ 10
Verified partner

TrimRx

Best for: best overall value

★★★★4.3

Editorial score · methodology

$179/mo
CompoundedSemaglutide
Get StartedRead full TrimRx review →

Frequently Asked Questions

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

Sources

The primary regulatory filings and peer-reviewed studies cited throughout this Maximus review:

Sources & methodology — as of July 2026
  1. 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)WeightLossRankings.org.
  2. 2.FDA — Compounding and the 503A Pharmacy FrameworkU.S. Food & Drug Administration.
  3. 3.FDA — Drug Shortages Database (current shortage listings)U.S. Food & Drug Administration.
  4. 4.PCAB — Pharmacy Compounding Accreditation Board StandardsAccreditation Commission for Health Care (ACHC) / PCAB.
  5. 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)Kaiser Family Foundation.
  6. 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)New England Journal of Medicine.PMID: 33567185.
  7. 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDAU.S. Food & Drug Administration.
  8. 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDAU.S. Food & Drug Administration.
  9. 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)New England Journal of Medicine.PMID: 35658024.
  10. 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDAU.S. Food & Drug Administration.
  11. 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDAU.S. Food & Drug Administration.
  12. 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)New England Journal of Medicine.PMID: 40334173.

Ready to start with Maximus?

Starting at $149.99/month. See current pricing and start your free consultation.